Arnott’s and Campbells have settled a lawsuit brought by Goodman Fielder accusing them of infringing its ‘Plantry’ mark under which it sells plant-based frozen meals, after the cookie company filed a cross-claim seeking to have the mark cancelled.
Food giants Arnott’s and Campbells have hit back in an infringement case over their ‘Plantly’ trade mark, filing a cross-claim that seeks to cancel rival Goodman Fielder’s ‘Plantry’ mark.
Food giants Arnott’s and Campbell will stop using their ‘Plantly’ logo on any new products pending the resolution of a trade mark infringement lawsuit brought by rival Goodman Fielder.
Singapore-owned food and beverage company Goodman Fielder has filed a trade mark infringement lawsuit against Arnott’s and Campbells after the two companies applied to register a trade mark that was one letter different to its own.
Neurim Pharmaceuticals can seek limited additional damages in a patent infringement case relating to its insomnia drug Circadin, after a judge granted a mid-trial bid to amend its pleadings against Generic Partners and Apotex.
The Copyright Tribunal has dismissed an application by media monitoring firm Isentia to lower per-clip rates payable to collecting house Copyright Agency, rejecting arguments the higher fees had led to a loss of customers.
A judge overseeing patent litigation over the painkiller Dynastat has urged the parties to narrow any issues in dispute, saying the excessive amounts of money spent in these types of cases could harm public perception.
The Dutch coffee company behind the popular Moccona brand has successfully opposed a coffee capsule patent sought by coffee machine maker K-fee.
The Full Federal Court has provided clarity around additional damages in patent cases by reducing the penalties liable to be paid by an Australian fencing and gate manufacturer found to have infringed a rival’s patent for a fence base.
The University of Sydney has emerged triumphant in its long running battle over the intellectual property rights of a glaucoma testing device, with the Federal Court ruling against opthalmic diagnostic tool manufacturer ObjectiVision.